TELEFLEX INCORPORATED (NYSE:TFX) Files An 8-K Submission of Matters to a Vote of Security HoldersItem 5.07.Submission of Matters to a Vote of Security Holders.
(a) The Company held its 2018 annual meeting of stockholders on May 4, 2018 (the “2018 Annual Meeting”). At the 2018 Annual Meeting, the Company’s stockholders voted on:
|
the election of four directors of the Company to serve for a term of three years and one director for a term of one year or, in each case, until their successors have been duly elected and qualified; |
|
the approval, on an advisory basis, of the compensation of the Company’s named executive officers; and |
|
the ratification of the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for 2018. |
(b) The final voting results with respect to each proposal are set forth below.
1.Election of Directors
Class of 2021
|
Name |
For |
Against |
Abstain |
Broker Non-Votes |
|
Candace H. Duncan |
37,875,601 |
360,835 |
57,322 |
1,979,026 |
|
Liam J. Kelly |
38,070,318 |
198,758 |
24,682 |
1,979,026 |
|
Stephen K. Klasko |
36,450,081 |
1,789,294 |
54,383 |
1,979,026 |
|
Stuart A. Randle |
37,462,411 |
775,606 |
55,741 |
1,979,026 |
Class of 2019
|
Name |
For |
Against |
Abstain |
Broker Non-Votes |
|
Andrew A. Krakauer |
38,065,852 |
175,244 |
52,662 |
1,979,026 |
2.Advisory Vote on Compensation of Named Executive Officers
|
For |
Against |
Abstain |
Broker Non-Votes |
|
37,010,060 |
1,184,636 |
99,062 |
1,979,026 |
3.Ratification of Appointment of Independent Registered Public Accounting Firm
|
For |
Against |
Abstain |
Broker Non-Votes |
|
39,518,832 |
709,800 |
44,152 |
About TELEFLEX INCORPORATED (NYSE:TFX)
Teleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company markets and sells its products to hospitals and healthcare providers, across the world, through a combination of its direct sales force and distributors. The Company operates through six segments: Vascular North America; Anesthesia North America; Surgical North America; Europe, the Middle East and Africa (EMEA); Asia, and Original Equipment Manufacturer (OEM). The Company manufactures its products at approximately 30 manufacturing sites, with manufacturing operations located in the Czech Republic, Germany, Malaysia, Mexico and the United States. The Company’s all others businesses include single-use respiratory, urology and cardiac care products, as well as capital equipment.
